The effects of orchidectomy, estrogens, and cyproterone acetate on plasma testosterone, LH, and fsh concentrations in patients with carcinoma of the prostate

Scandinavian Journal of Urology and Nephrology

Volumn 16, Issue 1, 1982, Pages 31-36

  Varenhorst, E ^a   Wallentin, L ^b   Carlstrom K ^c  

^a Department of Urology ^*  (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c Sabbatsberg Hospital   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYPROTERONE; CYPROTERONE ACETATE; ESTROGEN; ETHINYLESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; POLYESTRADIOL; POLYESTRADIOL PHOSPHATE; TESTOSTERONE;

CANCER HORMONE THERAPY; CASTRATION; ENDOCRINE SYSTEM; MAJOR CLINICAL STUDY; MALE GENITAL SYSTEM; ORCHIECTOMY; PROSTATE CARCINOMA; THERAPY;

AGED; CASTRATION; CYPROTERONE; CYPROTERONE ACETATE; ESTROGENS; FOLLICLE STIMULATING HORMONE; HUMAN; LUTEINIZING HORMONE; MALE; MIDDLE AGE; PROSTATIC NEOPLASMS; TESTIS; TESTOSTERONE;

EID: 0020024663     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.3109/00365598209179637     Document Type: Article

References (45)

1. Baker, H. W. G., Burger, H. G., de Kretser, D. M., Hudson, B., Rennie, G. C. & Stratton, W. G. 1975. The assessment of results following endocrine therapy for prostatic cancer, J Urol 113, 824.
2. Bartsch, W., Horst, H.-J., Becker, H. & Nehse, G. 1977. Sex hormone binding globulin capacity, testosterone, 5α-dihydrotestosterone, oestradiol and prolactin in plasma of patients with prostatic carcinoma under various types of hormonal treatment. Acta Endocrinol (Kbh) 85, 650.
3. Beck, P. H., McAninch, J. W., Goebel, J. L. & Stutzman, R. E. 1978. Plasma testosterone in patients receiving diethylstilbestrol. Urology 11 (2), 157.
4. Bracci, U., Di Silverio, F., Sciarra, R., Sorcini, G., Piro, C. & Santoro, F. 1977. Hormonal pattern in prostatic carcinoma following orchidectomy. 5-Year follow-up. Br J Urol 49, 161.
5. Bracci, U. 1979. Antiandrogens in the treatment of prostatic cancer. Eur Urol 5, 303.
6. Breuer, H. & Hoffman, W. 1967. The effect of cyproterone acetate on the biogenesis of testosterone and related compounds. In Testosterone. Proceedings, of a Workshop Conference (ed. J. Tamm), pp. 162-167. Georg Thieme Verlag, Stuttgart (Publ. 1968).
7. Brotherton, J. & Barnard, G. 1974. Some aspects of the effect of cyproterone acetate on levels of other steroid hormones in man. J Reprod Fertil 36, 373.
8. Byar, D. P. 1973. The Veterans Administration Cooperative Urological Research Group's Studies of cancer of the prostate. Cancer 32, 1126.
9. Clark, P. & Houghton, L. 1977. Subcapsular orchidectomy for carcinoma of the prostate. Br J Urol 49, 419.
10. Engel, K. & Karsznia, R. 1971. Effect of cyproterone acetate on the testosterone biosynthesis in rat testes. Hoppe-Seylers Z Physiol Chem 352, 559.
11. Fang, S. & Liao, S. 1969. Antagonistic action of antiandrogens on the formation of a specific dihydrotestosterone receptor protein complex in rat central prostate. Mol Pharmacol 5, 428.
12. Feldman, H. & Rodbard, D. 1971. Mathemathical theory of radioimmunoassay. In Principles of competitive protein binding assays (ed. W. D. Odell & W. H. Daughaday), pp. 158-203. J. Lippincott & Co, Philadelphia, Toronto.
13. Fosså, S. D., Fosså, J. & Aakvaag, A. 1977. Hormone changes in patients with prostatic carcinoma during treatment with estramustine phosphate. J Urol 118, 1013.
14. Fukutani, K., Isurugi, K., Ishida, H. & Yokoyama, M. 1979. Effects of estrogens on the testosterone levels of peripheral and spermatic vein blood in patients with prostatic cancer. J Urol 122, 624.
15. Geller, J., Fishman, J. & Cantor, T. L. 1975. Effect of cyproterone acetate on clinical, endocrine and pathological features of benign prostatic hypertrophy. J Steroid Biochem 6, 837.
16. Ghandian, R., O'Donoghue, E. P. N. & Puah, C. M. 1979. Changes in dihydrotestosterone and testosterone following endocrine manipulation in carcinoma of the prostate. Cancer Treat Rep 63 (7), 1192.
17. Graf, K.-J., Brotherton, J. & Neumann, F. 1974. Clinical uses of antiandrogens. In Handbook of epxerimental pharmacology, vol. 35/2, pp. 1-11. Springer-Verlag, Berlin, Heidelberg, New York.
18. Gupta, D., Jacobi, G. H., Blank, B. & Altwein, J. E. 1979. Androgens and sexhormone binding globulin (SHBG) in subjects with prostatic carcinoma and BPH. Cancer Treat Rep 63 (7), 1154.
19. Hammond, G. L., Kontturi, M., Vihko, P. & Vihko, R. 1978. Serum steroids in normal males and patients with prostatic diseases. Clin Endocrinol 9, 113.
20. Harper, M. E., Peeling, N. B., Cowley, T., Brownsey, B. C., Phillips, M. E. A., Groom, G., Fahmy, D. R. & Griffiths, K. 1976. Plasma steroid and protein hormone concentrations in patients with prostatic carcinoma, before and during oestrogen therapy. Acta Endocrinol (Kbh) 81, 409.
21. Houghton, A. L. & Jacobs, H. S. 1978. Advanced carcinoma of the prostate: Does the pre-treatment Leydig cell function determine the response to orchidectomy? Postgrad Med J 54, 261.
22. Huggins, C. & Hodges, C. V. 1941. Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1, 293.
23. Huggins, C., Stevens, R. E. & Hodges, C. V. 1941. Studies on prostatic cancer. II. The effects of castration on advanced carcinoma of the prostate gland. Arch Surg 43, 209.
24. Jönsson, G., Olsson, A. M., Luttrop, W., Cekan, Z., Purvis, K. & Diczfalusy, E. 1975. Treatment of prostatic carcinoma with various types of estrogen derivatives. Vitam Horm 33, 351.
25. Kaartinen, E., Laukkanen, M. & Saure, A. 1971. Metabolism of dehydroepiandrosterone by rat testicular homogenates: kinetic study at different temperatures; direct effect of 17/3-estradiol. Acta Endocrinol (Kbh) 66, 50.
26. Lagrelius, A., Carlström, K. & Lunell, N-D. 1981. Treatment with oral estrone sulphate in the female climacteric. II. Hormonal aspects. Acta Obstet Gynecol Scand 60, 33.
27. Mawhinney, M. G. & Neubauer, B. L. 1979. Actions of estrogen in the male. Invest Urol 16, 409.
28. Morse, H. C., Leach, D. R., Rowley, M. J. & Heller, C. G. 1975. Effect of cyproterone acetate on sperm concentration, seminal fluid volume, testicular cytology and levels of plasma and urinary ICSH, FSH and testosterone in normal men. J Reprod Fert 32 (3), 365.
29. Murono, P. E. & Payne. A. H. 1976. Distinct testicular 17-ketosteroid reductases, one in interstitial tissue and one in seminiferous tubules. Differential modulation by testosterone and metabolites of testosterone. Biochim Biophys Acta 450, 89.
30. Murray, M. A. F., Anderson, D. C., Bancroft, J. H. J., Tennant, T. G. & Carr, P. J. 1973. Sex-hormone-binding globulin, luteinizing hormone and testosterone in man: Effects of oestrogen and cyproterone acetate. J Endocrinol 59, xxI-xxII.
31. Neumann, F. V., Berswordt-Wallrabe, R., Elger, W., Steinbeck, H., Hahn, J. D. & Kramer, M. 1970. Aspects of androgen-dependent events as studied by antiandrogens. Recent Progr Hormone Res 26, 337.
32. Robinson, M. R. G. & Thomas, E. S. 1971. Effect of hormonal therapy on plasma testosterone levels in prostatic carcinoma. Br Med J 3, 391.
33. Sanfort, E. J., Paulson, D. F., Rohner, T. J., Drage, J. R., Santen, R. J. & Bardin, C. W. 1977. The effect of castration on adrenal testosterone secretion in men with prostatic carcinoma. J Urol 118, 1019.
34. Sanwal, P. C., Sundby, A. & Edqvist, L. E. 1974. Diurnal variations of peripheral plasma levels of testosterone in bulls measured by a rapid radioimmunoassay procedure. Acta Vet Scand 15, 90.
35. Schoonees, R., Schalch, D. S. & Murphy, P. 1971. The hormonal effects of antiandrogen (SH-714) treatment in man. Invest Urol 8, 635.
36. Sciarra, F., Sorcini, G., di Silverio, F. & Gogliardi, V. 1973. Plasma testosterone and androstenedione after orchidectomy in prostatic adenocarcinoma. Clin Endocrinol 2, 101.
37. Shearer, R. J., Hendry, W. F., Sommerville, I. F. & Fergusson, J. D. 1973. Plasma testosterone: An accurate monitor of hormone treatment in prostatic cancer. Br J Urol 45, 668.
38. Sköldefors, H., Carlström, K. & Eneroth, P. 1978. Influence of aging upon the serum hormone levels in the male. Int J Andr l. 308.
39. Smith, R. B., Walsh, P. C. & Goodwin, W. E. 1973. Cyproterone acetate in the treatment of advanced carcinoma of the prostate. J Urol 110, 106.
40. Tveter, K. J., Attramadal, A., Aakvaag, A. & Hansson, V. 1971. Androgenic receptors in rat and human prostate. Advanced in Bioscience 7, 193.
41. Union Internationale Contre le Cancrum, TNM classification of malignant tumours, Geneva, 1978.
42. Wein, A. J. & Murphy, J.J. 1973. Experience in the treatment of prostatic carcinoma with cyproterone acetate, J Urol 109, 68.
43. Veterans Administration Cooperative Urological Research Group. Treatment and survival of patients with cancer of the prostate. Surg Gyn Obstet 124, 1011, 1967.
44. Weidner, W., Krause, W., Pust, R., Engstfeld, J. & Rothauge, C. F. 1978. Testosteron, FSH- und LH-Spiegel im Serum bei Patienten mit Prostatakarzinom unter Behandlung mit weiblichen Hormonen. Helv Chir acta 45, 287.
45. Zumoff, B., Rosenfeld, R. S., O'Connor, J. F. & Fukushima, D. K. 1979. Abnormal plasma hormone levels in prostate cancer. Cancer Treat Rep 63, 1154.